cellular
actin
cytoskeleton
static
phenomenon
sole
provid
structur
integr
cell
instead
constitut
activ
throughout
cellular
life
involv
key
process
intracellular
organis
motil
intracellular
transport
within
cell
evid
viral
entri
cell
goe
beyond
initi
bind
virusspecif
cell
surfac
receptor
fact
necessit
interact
actin
cytoskeleton
regul
would
otherwis
act
barrier
effect
infect
given
unparallel
divers
demonstr
viru
speci
unsurpris
mani
virus
evolv
uniqu
method
subvert
barrier
cellular
actin
present
even
hijack
chief
regul
rho
famili
gtpase
activ
promot
viral
entri
subsequ
nuclear
infiltr
rho
famili
gtpase
constitut
divers
group
cell
signal
molecul
present
eukaryot
organ
play
integr
role
control
cellular
actin
dynam
cumul
macroeffect
cell
morpholog
membran
traffick
adhes
relat
protein
form
famili
express
mammal
isoform
rhoa
isoform
subject
studi
characteris
rhoa
long
known
produc
individu
characterist
effect
cellularcytoskeleton
includ
lamellipodia
filopodia
stress
fibr
format
individu
effect
rho
gtpase
enact
downstream
effector
regul
includ
complex
wiskottalrdich
syndrom
wasp
protein
myosin
light
chain
kinas
phosphatas
mlck
result
divers
portfolio
effect
actindynam
summaris
figur
key
regulatori
action
rho
gtpase
capac
cycl
activ
inact
state
rho
gtpase
bind
gtp
gdp
capabl
exert
intrins
gtpase
activ
bound
gtp
rho
gtpase
activ
state
abl
bind
activ
downstream
signal
molecul
realis
effect
cellular
actinnetwork
cycl
activ
gtpbound
inact
gdpbound
state
spontan
occur
rho
gtpase
due
intrins
gtpase
activ
within
cell
regul
three
class
relat
molecul
guanin
exchang
factor
gef
gtpase
activ
protein
gap
guanin
nucleotidedissoci
inhibitor
gdi
although
rho
gtpase
associ
characterist
effect
cellular
cytoskeleton
great
degre
overlap
crosstalk
dynam
action
within
rho
gtpase
signal
pathway
demonstr
consid
lim
domain
kinas
limk
scofilin
pathway
unit
three
major
rho
gtpase
also
capabl
factin
polymeris
depolymeris
effect
coupl
small
globular
morpholog
expos
target
site
inhibitor
characteris
specif
rho
gtpase
signal
pathway
present
extrem
challeng
task
attempt
studi
individu
gtpase
function
heavili
restrict
past
initi
attempt
reli
use
indiscrimin
agent
like
jasplakinolid
clostridium
toxin
b
either
target
entir
cellular
cytoskeleton
gtpase
regul
howev
owe
import
rho
gtpase
appear
play
malign
progress
recent
year
result
develop
sever
specif
rhoa
illustr
figur
afford
us
unpreced
capac
studi
rho
gtpase
involv
viral
process
despit
advanc
adopt
novel
gtpase
inhibitor
extrem
limit
field
even
studi
human
immunodefici
viru
hiv
cell
entri
applic
agent
prolif
investig
unwarrantedli
skew
toward
target
rhoa
role
left
mostli
overlook
correct
oversight
review
aim
first
present
grow
evid
base
primari
role
signal
cell
entri
arriv
upon
use
novel
specif
inhibitori
agent
highlight
number
rna
viru
speci
literatur
suggest
similar
studi
like
achiev
similar
success
whilst
current
signal
model
propos
share
import
major
rho
gtpase
cell
entri
unlik
suffici
detail
pictur
instead
reflect
overlap
activ
rho
gtpase
ongo
difficulti
target
specif
investig
often
reli
target
downstream
effector
protein
activ
kinas
pak
nonspecif
individu
gtpase
use
complex
techniqu
small
interf
rna
sirna
transfect
dominantneg
gtpase
howev
develop
novel
specif
gtpaseinhibit
agent
facilit
attempt
characteris
individu
import
rhoa
play
entri
process
previous
discuss
though
downstream
effector
strongli
implic
target
inhibit
signal
shown
effect
inhibit
tcell
entri
consid
overlap
natur
signal
find
may
support
altern
model
counterpart
signal
pathway
instead
play
lead
entri
process
follow
hypothesi
possibl
signal
pathway
investig
group
two
novel
inhibitor
employ
investig
inhibit
infect
three
differ
pseudotyp
viru
strain
intersectinspecif
found
significantli
inhibit
infect
three
pseudotyp
virus
dosedepend
manner
cell
line
investig
tzmbl
highest
dose
use
infect
tropic
pseudotyp
virus
reduc
tzmbl
cell
virus
cell
broaderact
show
almost
inhibitori
effect
pseudotyp
viru
infect
fact
increas
infect
viru
tzmbl
cell
maximum
effect
control
cell
produc
infect
whilst
specif
alloster
inhibitor
bind
blanket
inhibitori
effect
activ
indiscrimin
inhibit
signal
may
enigmat
effect
rho
signal
pathway
note
origin
character
agent
potenti
offtarget
effect
molecul
intersectin
specif
link
pathway
logic
suggest
predominantli
inhibit
signal
addit
waspwav
signal
exist
parallel
pathway
discuss
earlier
activ
share
waspwav
downstream
effector
previous
implic
necessari
nuclear
migrat
data
support
hypothesi
pathway
rather
key
tcell
entri
process
similarli
member
paramyxoviru
famili
rsv
origin
believ
enter
target
cell
fusogen
manner
via
rsv
fusion
rsvf
glycoprotein
found
viral
envelop
theori
evidenc
initi
dequench
assay
fluoresc
lipid
probe
target
cell
plasma
membran
dequench
incub
rsv
virion
indic
mix
dilut
target
cell
plasma
membran
attribut
rsv
fusion
demonstr
sever
studi
rsv
entri
process
independ
endosom
acidif
support
fusogen
entri
howev
evid
recent
year
suggest
entri
process
may
involv
endocytot
process
target
sirna
screen
hela
cell
kolokolstov
et
al
demonstr
knockdown
variou
gene
implic
endocytosi
function
confer
protect
rsv
infect
amongst
protect
gene
clathrin
light
heavi
chain
gene
author
took
suggest
clathrinmedi
endocytot
entri
process
addit
intersectin
compon
actin
demonstr
convey
protect
rsv
infect
inhibit
develop
sanjuanvergara
et
al
demonstr
use
dualwavelength
imag
rsv
entri
involv
initi
dock
hemifus
cholesterol
rich
membran
domain
group
identifi
follow
actin
reorganis
applic
small
molecul
inhibitor
reduc
rsv
infect
half
untreat
cell
indic
crucial
role
signal
recent
theori
macropinocytot
entri
propos
krzyzaniak
et
al
clearli
demonstr
primari
role
rsv
cellentri
demonstr
f
nviral
protein
stain
rsv
endocytos
process
clathrin
dynamin
phindepend
group
investig
effect
variou
actindisrupt
agent
rsv
infect
though
rhoa
inhibit
moder
effect
inhibit
use
complex
activ
inhibitor
sever
restrict
rsv
infect
addit
inhibit
downstream
effector
wasp
show
moder
decreas
infect
target
individu
individu
rv
strain
thought
enter
target
cell
distinct
endocytot
pathway
poorli
characteris
past
becom
increasingli
well
understood
rhesu
rotaviru
rrv
one
extens
studi
rv
strain
earli
attempt
determin
entri
process
use
lysosomotrop
agent
endosom
traffick
blocker
demonstr
entri
process
follow
classic
endocytot
pathway
use
newer
domin
neg
protein
transfect
techniqu
et
al
abl
characteris
rrv
entri
dynamindepend
clathrin
caveolaeindepend
process
later
also
describ
follow
work
strain
rrv
uk
wa
characteris
utilis
clathrindepend
process
marco
et
al
later
show
express
domin
neg
variant
target
cell
inhibit
infect
clathrindepend
rv
uk
strain
suggest
despit
differ
substanti
rv
entri
process
share
common
entri
rout
cov
still
debat
variou
rout
propos
variou
cov
strain
includ
poorli
characteris
clathrin
caveolaeindepend
entri
pathway
sever
acut
respiratori
syndrom
sar
viru
lipidraft
caveolaemedi
entri
human
cov
strain
classic
clathrin
endocytosi
commonli
studi
mous
hepat
coronaviru
mhv
recent
studi
use
sirna
techniqu
help
elucid
mani
aspect
mhv
cov
entri
also
identifi
critic
potenti
role
process
use
high
throughput
sirna
screen
nomura
et
al
demonstr
silenc
two
major
constitu
complex
result
signific
reduct
mhv
infect
use
actin
cytoskeleton
alter
agent
earli
stage
infect
similar
restrict
effect
infect
point
gtpase
specif
involv
entri
process
furthermor
author
note
though
conclud
mhv
like
enter
clathrin
endocytosi
infect
sever
inhibit
ethylisopropyl
amilorid
eipa
agent
primarili
associ
macropinocytosi
blockag
eipa
inde
known
hallmark
effect
inhibit
macropinocytosi
actual
caus
effect
prevent
necessari
signal
involv
find
restrict
infect
due
knockdown
actin
cytoskeleton
disrupt
eipa
strongli
suggest
signal
mhv
cell
entri
process
ebov
cell
entri
known
mediat
fusion
glycoprotein
sever
theori
entri
process
present
time
current
opinion
hold
entri
either
via
clathrinendocytosi
macropinocytosi
evid
suggest
rho
famili
gtpase
involv
first
identifi
quinn
et
al
demonstr
rhob
rhoc
overexpress
via
plasmid
result
increas
suscept
ebov
infect
cell
later
work
investig
macropinocytot
entri
process
build
find
indic
key
role
mulherkar
et
al
demonstr
ebov
infect
macropinocytot
permiss
cell
sever
reduc
eipa
actin
polymeris
inhibitor
furthermor
gtpase
also
investig
group
determin
ebov
entri
depend
suggest
rather
specif
rho
gtpase
involv
find
support
aleksandrowicz
et
al
reproduc
find
eipa
inhibit
ebov
infect
despit
contemporari
global
interest
ebov
studi
specif
target
undertaken
leav
us
unabl
characteris
involv
studi
discuss
suggest
mani
rna
virus
share
depend
achiev
success
infect
involv
thoroughli
characteris
like
global
burden
ongo
explor
viral
lifecycl
warrant
hope
identifi
new
potenti
drug
target
whilst
spectrum
techniqu
rang
broader
use
gener
actin
inhibit
target
investig
sirna
knockdown
specif
signallingrel
gene
provid
bulk
initi
data
use
employ
novel
agent
clearest
indic
use
elucid
without
use
precis
agent
easi
overlook
involv
even
misinterpret
process
due
oftreport
overlap
function
rho
famili
gtpase
inde
given
studi
variou
seem
demonstr
inhibit
function
may
result
dysregul
rho
famili
gtpase
possibl
broadlyact
agent
use
past
screen
involv
viru
speci
entri
process
may
produc
fals
neg
result
suggest
use
mani
viral
speci
deserv
reinvestig
mani
studi
mention
review
employ
agent
unfortun
leav
literatur
unabl
equal
characteris
use
amongst
viral
speci
mention
signpost
clear
need
research
even
fundament
topic
furthermor
though
renown
divers
rna
viru
speci
give
rise
ampl
interspeci
variat
even
within
narrow
realm
review
identifi
two
specif
scenario
induct
cell
entri
process
unit
diverg
speci
discuss
firstli
entri
via
induct
macropinocytosi
seem
involv
obligatori
use
increasingli
recognis
altern
sometim
prefer
method
entri
share
mani
virus
includ
ebov
rsv
discuss
earlier
determin
whether
induct
macropinocytot
entri
process
differ
speci
could
identifi
conserv
viral
process
research
secondli
one
particular
pathway
identifi
unit
multipl
rna
virus
studi
mention
pathway
promot
intersectin
inhibit
constitu
presum
specif
target
entir
pathway
via
shown
inhibit
infect
cov
rsv
suggest
conserv
compon
entri
process
diverg
speci
consid
within
field
alon
call
consider
even
one
attempt
employ
gtpaseinhibit
agent
treatment
tempt
specul
pharmacolog
target
viral
use
could
constitut
basi
broadspectrum
antivir
therapi
beyond
present
howev
remain
hamstring
limit
knowledg
pathway
molecul
even
agent
inhibit
involv
investig
viral
use
pathway
clearli
warrant
studi
specif
agent
greater
detail
